Similarly, we predicted that the inhibitory interaction Mdm2 - p53 in the ‘chronic myeloid leukemia’ pathway is a ubiquitination reaction. The gene discussed is MDM2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.